Reducing the time and expense of engineering PROTAC degraders remains a significant challenge in the pharmaceutical industry. A PROTAC is composed of an E3 ligase ligand (E3-L), a protein of interest ...
Blind and low-vision programmers have long been locked out of three-dimensional modeling software, which depends on sighted ...